AN OPEN-LABEL, MULTICENTER, PHASE Ib/II TRIAL EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF MOSUNETUZUMAB (BTCT4465A) IN COMBINATION WITH POLATUZUMAB VEDOTIN IN PATIENTS WITH B-CELL NON HODGKIN LYMPHOMA
This study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of mosunetuzumab in combination with polatuzumab vedotin in patients with B-cell Non-Hodgkin lymphoma.
Lone Tree Medical Center
University of Colorado Hospital
Manali Kamdar, MD
Protocol Number: 18-1439
More information available at ClinicalTrials.gov: NCT03671018
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers